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Strengths and limitations of this study
 ► This is the first systematic review evaluating the 
reporting quality of studies developing and/or vali-
dating machine learning (ML) methods for medical 
diagnosis within the medical literature.
 ► Using a systematic approach, this review included 
studies published within the Medline Core Clinical 
Journals, these journals cover all areas of clinical 
and public health.
 ► The review used Transparent Reporting of a multi-
variable prediction model for Individual Prognosis Or 
Diagnosis to help extract information concerning the 
participants within the reviewed studies.
 ► This review only focused on the reporting quality 
and, therefore, did not evaluate the statistical meth-
odology and conduct of studies using ML diagnostic 
systems.
 ► Although a risk of bias assessment is not essential 
for research on research, the following review did 
not use the risk of bias assessment tool.
AbStrACt
Aims We conducted a systematic review assessing the 
reporting quality of studies validating models based on 
machine learning (ML) for clinical diagnosis, with a specific 
focus on the reporting of information concerning the 
participants on which the diagnostic task was evaluated 
on.
Method Medline Core Clinical Journals were searched for 
studies published between July 2015 and July 2018. Two 
reviewers independently screened the retrieved articles, 
a third reviewer resolved any discrepancies. An extraction 
list was developed from the Transparent Reporting of a 
multivariable prediction model for Individual Prognosis 
Or Diagnosis guideline. Two reviewers independently 
extracted the data from the eligible articles. Third and 
fourth reviewers checked, verified the extracted data as 
well as resolved any discrepancies between the reviewers.
results The search results yielded 161 papers, of which 
28 conformed to the eligibility criteria. Detail of data 
source was reported in 24 of the 28 papers. For all of 
the papers, the set of patients on which the ML- based 
diagnostic system was evaluated was partitioned from 
a larger dataset, and the method for deriving such set 
was always reported. Information on the diagnostic/non- 
diagnostic classification was reported well (23/28). The 
least reported items were the use of reporting guideline 
(0/28), distribution of disease severity (8/28 patient flow 
diagram (10/28) and distribution of alternative diagnosis 
(10/28). A large proportion of studies (23/28) had a 
delay between the conduct of the reference standard 
and ML tests, while one study did not and four studies 
were unclear. For 15 studies, it was unclear whether the 
evaluation group corresponded to the setting in which the 
ML test will be applied to.
Conclusion All studies in this review failed to use 
reporting guidelines, and a large proportion of them lacked 
adequate detail on participants, making it difficult to 
replicate, assess and interpret study findings.
PrOSPErO registration number CRD42018099167.
IntrOduCtIOn
Machine learning (ML) is a rapidly devel-
oping area, characterised as the science of 
training computers to conduct specific tasks, 
such as classification or prediction, without 
explicit programming, but where decisions 
are taken based on patterns and relationships 
within large and complex datasets.1 Over the 
past decade, access to large amounts of clin-
ical data and the development of new ML 
techniques have led to a rise in the application 
of ML methods to medicine.2 3 Due to their 
propensity to facilitate and promote timely 
and objective clinical decision- making, ML 
methods have been applied to gain valuable 
insights into clinical diagnoses. For example, 
ML methods have been used to diagnose skin 
cancer using skin lesion images,4 diagnose 
cerebral aneurysms using clinical notes5 and 
diagnose stroke using neuroimaging data6—
see box 1 for an example of ML- based diag-
nostic system.
While there is no consensus on the defi-
nition, a key principle of ML models is that 
they are developed based on the automatic 
extraction of patterns from data.7 In contrast 
to traditional statistics, whereby models are 
explicitly programmed based on statistical 
theory and assumptions, ML models learn 
from examples without the need for explicit 
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box 1 
Machine learning (ML) is the ability to create algorithms to accomplish 
specific tasks without explicitly programming them, but rather take de-
cisions based on previously seen data. Here is a summary of the steps 
when creating ML algorithms:
Model development
Step 1: Defining the research problem. This could be broken down to 
either a classification, regression or a clustering problem.
Step 2: Identification of data sources and formats. Data could be in 
various formats (eg, images, text, speech or numerical), and data could 
come from various sources, such as hospital, insurance databases or 
previous research projects.
Step 3: Training and test set derivation. Here, the data could be broken 
down into two independent components: the training set and test set. 
The training set is used to create the ML algorithm and the test set is 
used to evaluate the ML algorithm.
Step 4: Model development. The model is developed using the training 
dataset. The model could be either supervised or unsupervised (su-
pervised models require labelled data, whereas unsupervised models 
do not). The loss function and the methods for handling outliers and 
missing data are also described. A portion of the training set, the model 
selection set, is often withheld from model training to allow for model 
selection and to avoid overfitting.
Step 5: Evaluation of the model. The test set is used to evaluate the ML 
algorithm using a variety of metrics to compare the prediction with the 
gold standard outcome label (often referred to as ground truth).
Model validation
To obtain an accurate assessment of model’s performance in a clinical 
setting, the model must be validated against data, which is drawn from 
a clinical cohort. Internal validation refers to a model being evaluated 
on a cohort taken from the same setting as the data used to develop 
the model. External validation is where the cohort data are taken from 
a separate setting, which overcomes any systematic biases present in 
the data source used for model validation.
It is worth noting that one potential area for confusion is the differing 
meanings of the terms test set and validation set between the ML and 
medical research community. A medical researchers validation set is 
an ML test set.
rules to make decisions.8 Generally, a researcher devel-
oping an ML model has access to a large dataset that is 
divided into a training set and a test set (see box 1). The 
training set is used to develop an ML model that will learn 
the relationships between available clinical data and an 
outcome of interest (eg, a diagnosis). The performance 
of the ML model is then evaluated by applying it to the 
test set. As ML models are only as good as the data used 
to train them, it is vital to emphasise the importance of 
data quality.9
Despite their popularity, the promising applications 
of ML- based diagnostic systems come with its own set 
of pitfalls. Studies using ML for medical diagnosis may 
contain systematic errors in both the design and execu-
tion.10–12 For instance, selection bias can occur if the 
sample used to produce the ML- based diagnostic system 
is not entirely representative of the population on which 
the model may be used in the future.11 Repeated eval-
uation of model performances against the same test 
set may result in the selected model overfitting the test 
set, resulting in an over- optimistic assessment of model 
performance.13 These methodological biases can make 
it difficult to generalise conclusions from the results 
yielded. This could lead to erroneous yet devastating clin-
ical decisions, that is, recommending a medical treatment 
to an individual that is different from those in the popula-
tion the that treatment was developed and validated on.14
There is a parallel between what ML researchers refer 
to as ‘test set’ and the ‘population on which a diagnostic 
test is evaluated’ within diagnostic accuracy studies. The 
diagnostic accuracy of an ML- based systems is reliant on 
demographic and clinical characteristics of the popula-
tion in which it was applied on, therefore, if the cohorts 
are not a representative sample of the targeted popula-
tion, then the generalisability of the study results may 
be limited. A further hindrance to the application of 
ML methods for medical diagnosis (and more gener-
ally in biomedical research) is that ML researchers may 
not be familiar with the requirements and guidelines 
that biomedical research have collectively established to 
ensure transparent and unbiased evidence- based knowl-
edge accumulation.15 16
Clinical prediction models undergo a scientifically 
rigorous process to establish their diagnostic accuracy, 
which encompasses their safety, validity, reproducibility, 
usability and reliability. Highlighting the importance of 
transparent and rigorous reporting of clinical predic-
tions models accuracy studies, particularly as the diag-
nostic prediction models of an instrument can vary 
greatly due to factors such as population characteris-
tics, clinical setting, disease prevalence and severity as 
well as aspects of test execution and interpretation.16 
To aide with and standardise this process, Transparent 
Reporting of a multivariable prediction model for Indi-
vidual Prognosis Or Diagnosis (TRIPOD) guideline was 
set in place. The TRIPOD is an internationally accepted 
reporting guideline that was developed to improve 
the reliability and value of clinical prediction models 
through the promotion of transparent and accurate 
reporting.16
In medical research, reporting guidelines are imple-
mented to aid in the transparent evaluation, usability and 
reproducibility of a diagnostic instrument.17 Luo et al18 
have constructed a reporting guideline for the develop-
ment and usage of ML predictive models in biomedical 
research. This is an important step towards a rigorous and 
robust approach to the usage of ML methods in medical 
research. Since publication in December 2016 (up to May 
2019), the guideline of Simera et al, which is currently 
available on The Enhancing the QUAlity and Transpar-
ency Of Health Research network website,19 has garnered 
only ~50 citations. Additionally, in 2015, a more specific 
and robust guideline was developed to aid the reporting 
of prediction models used in prognostic and diagnostic 
studies (TRIPOD).16 TRIPOD has ~1000 citations demon-
strating that is has been accepted by the community as 
a useful set of guidelines for diagnostic/prognostic 
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Table 1 Item list used to extract eligible papers
Item groups Item list Detailed items
General 
characteristics
Diagnostic task What is the target condition?
  Study objective Is the study aiming at the development of a diagnostic method, evaluation of 
a diagnostic method or both?
  Target population What is the population targeted by the diagnostic test?
Methods Data sources Where and when potentially eligible participants were identified (setting, 
location and dates)
  Data split Method for partitioning the evaluation set from the training data. To assess 
whether participants formed a consecutive, random or convenience series.
  Test dataset eligibility criteria On what basis potentially eligible participants were identified within the test 
dataset (such as symptoms, results from previous tests, inclusion in registry).
Results Baseline characteristics Baseline demographic and clinical characteristics of participants
  Diagnosis/non- diagnosis 
classification
Classification of the diagnosed and non- diagnosed patients within the test 
set.
  Flow diagram Flow of participants, using a diagram.
  Severity Distribution of severity of disease in those with the target condition.
  Alternative diagnosis Distribution of alternative diagnoses in those without the target condition.
  Difference between reference 
test and ML test
Is there a time interval between index test and reference standard?
  Applicability Does the evaluation population correspond to the setting in which the 
diagnosis test will be applied?
ML, machine learning.
prediction. In this work, we evaluate whether ML studies 
make use of these guidelines.
To date, there have been no studies evaluating the 
reporting quality of studies using ML methods, particu-
larly diagnostic studies. Knowing this may aid in the evalu-
ation of reporting standards employed by ML researchers. 
In this review, we focus on medical research studies that 
used ML methods to aid clinical diagnosis. Further, we 
have narrowed our review to applied ML methods, which 
are envisaged to be clinically useful, in which the end 
users are practitioners and research consumers.
We aimed to produce a systematic review assessing the 
reporting quality of studies developing or validating ML 
models for clinical diagnosis, with a specific focus on the 
reporting of information concerning the participants on 
which the diagnostic task was evaluated.
MEthOdS
This review was registered with International prospec-
tive register of systematic reviews on 30 July 2018. The 
framework used for this methodological systematic review 
is Preferred Reporting Items for Systematic reviews and 
Meta- Analyses guideline for systematic reviews.20
Literature search
On July 2018, two authors (MY and JL) independently 
searched through the Medline Core Clinical Journals for 
articles developing or validating ML models for clinical 
diagnosis. Core Clinical Journals, also known as Abridged 
Index Medicus, is a filter option within Medline that 
limits to clinically useful journals. This is a selection of 119 
English- language journals that focus on clinical studies 
and that are considered to be of immediate interest to 
practising physicians.21 Using this filter excludes journals 
in bioinformatics or computational biology, which are 
highly likely to include articles explaining the develop-
ment of ML- based diagnosis systems. However, these jour-
nals might not target clinicians. In addition to this, due 
to the ever- expanding ML literature, we have narrowed 
our review to studies published between July 2015 and 1 
July 2018. See online supplementary file 1 for the search 
strategy.
Subsequent to the literature search, the two reviewers 
(MY and JL) screened the title and abstracts of the search 
results. Once the eligible papers were identified and 
retrieved, both the first reviewer (MY) and the second 
reviewer (JL) independently screened the full articles for 
eligibility. Discrepancies between the two reviewers were 
discussed and resolved by a third reviewer (IA).
Inclusion and exclusion
Studies were included if they used ML for clinical diag-
nosis, for example if they used statistical techniques to 
conduct classification, regression or clustering based on 
clinical data for disease diagnosis without being explic-
itly programmed. Other inclusions were primary study 
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Table 2 Study characteristics
Items Total n (%)
Year
  2015 4 (14)
  2016 9 (32)
  2017 12 (43)
  2018 3 (11)
Journals
  Radiology 8 (29)
  JAMA 2 (7)
  Brain 2 (7)
  American Journal of Roentgenology 2 (7)
  Neurology 1 (3)
  Medicine 1 (3)
  Surgery 1 (3)
  Chest 1 (3)
  Gastroenterology 1 (3)
  Journal of the American College of 
Cardiology
1 (3)
  Journal of Allergy and Clinical Immunology 1 (3)
  American Journal of Clinical Pathology 1 (3)
  American Journal of Ophthalmology 1 (3)
  The Journal of Infectious Diseases 1 (3)
  Digestive Diseases and Sciences 1 (3)
  The British Journal of Radiology 1 (3)
  The Journal of Pediatrics 1 (3)
Clinical Specialty
  Oncology 13 (47)
  Neurology 5 (18)
  Immunology 2 (7)
  Ophthalmology 2 (7)
  Others specialties* 6 (21)
Task
  Development and evaluation 27 (97)
  Evaluation 1 (3)
*Other clinical specialities include cardiology, gastroenterology, 
infectious disease, psychiatry, endocrinology and various.
Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses flow diagram. From: Moher D et al.34
designs that evaluated the accuracy of such ML- based 
systems for diagnostic tasks, and articles in the English 
language. Studies were excluded if they did not report 
original research, if they were systematic reviews, had no 
abstract or did not specify the type of ML model adopted.
Extraction list
For studies developing, evaluating or updating clinical 
prediction models (this includes diagnosis), the TRIPOD 
provides guidance on reporting the key items. As it stands, 
TRIPOD is the most rigorous and relevant guideline for 
evaluating the use of ML methods for medical diagnosis. 
As such, an extraction list based on the TRIPOD check-
list was developed. The focus of the extraction list was 
to extract information about the participants on which 
the diagnostic task was evaluated on, namely selection 
method and population characteristics. We additionally 
extracted general information concerning the diagnostic 
tasks, namely the target condition and the target popula-
tion. The extraction list was tested and validated by two 
reviewers (MY and JL), by applying it on a random sample 
of the eligible papers.
data extraction
Two reviewers (JL and PS) independently extracted the 
data from the eligible articles based on the items listed 
in table 1. For each of the items, reviewers declared if the 
item was clearly reported (yes/no/unclear) and justify the 
declaration by citing the manuscript verbatim, as well as 
providing a written explanation if the reporting was consid-
ered unclear. The third and fourth reviewers (MY and IA) 
checked and verified the extracted data and resolved any 
disagreements between the reviewers through discussion.
data analysis
Findings from the included studies demonstrating study 
characteristics, reporting quality and presence of bias 
were presented in descriptive statistics and figures.
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Table 3 Reporting quality
Items Reported, n (%) Not reported, n (%) Unclear, n (%)
Methods
  Data source 24 (86) 0 (0) 4 (14)
  Data split methods 28 (100) 0 (0) 0 (0)
  Test set eligibility criteria (evaluation set) 23 (82) 5 (18) 0 (0)
Results
  Baseline characteristic 17 (61) 11 (39) 0 (0)
  Diagnosis/non- diagnosis classification 23 (82) 4 (14) 1 (4)
  Flow diagram 10 (36) 18 (64) 0 (0)
  Disease severity 8 (29) 18 (64) 2 (7)
  Alternative diagnosis 10 (36) 18 (64) 0 (0)
  Use of reporting guideline 0 (0) 28 (100) 0 (0)
Table 4 Presence of bias
Items Yes, n (%) No, n (%) Unclear, n (%)
Is there a time interval between reference standard ML test? 23 (82) 1 (4) 4 (14)
Does the test population correspond to the population/setting in which the 
diagnosis test will be applied?
5 (18) 8 (29) 15 (54)
Patient and public involvement
There was no patient or public involvement in any 
phase of this study, this included the development of the 
research question, the analysis and the conclusions.
rESuLtS
The search yielded 161 papers, of which 28 conformed to 
the eligibility criteria, see figure 1. During the screening 
of the title and abstract, most papers were excluded 
due to the search term ‘CAD’ being analogous to both 
‘computer- aided detection’ and coronary artery disease’. 
During the full- text review, eleven papers were excluded 
because they did not use ML methods for medical diag-
nosis, and three papers were excluded because they did 
not use ML method but were captured in the search 
because they studied coronary artery disease (CAD).
Study characteristics
The study characteristics of the all eligible studies are 
presented in table 2 (see online supplementary file 1 
for list of studies). From the papers extracted, majority 
of the studies were published in 2017 (43%) and mostly 
in the Radiology journal (29%). Oncology was the most 
researched domain (47%), followed by Neurology (18%). 
The majority of studies focused on model development 
(97%), with only one study looking at model validation.
reporting quality
Detail of the data source was reported in 86% of the 
papers, with all studies providing information on the 
separation method for deriving the evaluation set from 
the larger dataset. Eighty- two per cent of studies reported 
eligibility criteria for both evaluation set. Information 
on the diagnostic/non- diagnostic classification evalu-
ation metric used was included in 82% of all papers. 
The least- reported items were use of reporting guide-
line (0%), distribution of disease severity (29%), patient 
flow diagram (36%), distribution of alternative diagnosis 
(36%) and baseline characteristic (61%). See table 3 for 
a full breakdown of reporting quality.
Presence of bias
Within the eligible studies, 82% had a a time interval 
between the conduct of the reference standard and ML 
test (table 4). Within 54% of studies, it was unclear whether 
the study populations corresponded to the setting in 
which the diagnostic test will be applied to. However, in 
29% of studies, the clinical setting of the gathered evalu-
ation dataset did not correspond to the clinical setting in 
which study authors hoped it would be applied.
dISCuSSIOn
This review found that studies developing or validating 
ML- based systems for clinical diagnosis failed to use 
reporting guidelines and lacked adequate detail for assess-
ment, interpretation and reproducibility. With nearly all 
studies providing detail on data sources, eligibility criteria 
and diagnosis classification, only a few studies reported 
study participant flow diagram, distribution of disease 
severity and distribution of alternative diagnosis. Our find-
ings are in line with those of Faes et al recent systematic 
reviews22 in which they found poor reporting and poten-
tial biases arising from study design in studies using ML 
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methods for classifying diseases from medical imaging. 
Similarly, in another systematic review, Christodoulou et 
al23 found studies comparing the performance of logistic 
regression models with ML models for clinical prediction 
to have poor methodology and reporting quality.
A high number of studies reviewed had a time differ-
ence between the conduct of the reference test and that 
of ML- based diagnostic systems, suggesting the poten-
tial for incorporation bias.24 25 This is largely an issue in 
ML- based diagnostic systems where labelling is the gold 
standard, but patient data are labelled retrospectively. 
This may happen several years after initial data collection 
and in a different setting.
In more than half of the studies, it was unclear whether 
the study population corresponded to the setting in 
which the ML diagnostic system will be used in. However, 
in a third of the reviewed studies, the test populations did 
not correspond to the populations in which tests were 
hoped to be applied to, further limiting their generalis-
ability. In addition to this, studies utilising ML- based diag-
nostics systems fail to report baseline characteristics. This 
could be problematic; within diagnostic accuracy studies 
it is imperative to report sample characteristics as this 
aid researchers, research consumers and practitioners in 
determining the relevancy and applicability of study find-
ings to a wider setting.
Information on data source was unclear in four studies; 
this is vital in evaluating the source and methods used 
to derive study samples. In diagnostic studies the use of 
different methods to derive the evaluation sample from 
the wider population could lead to more or less accu-
rate estimation of the diagnostic performance. The ideal 
method for sampling should be based on probability 
and not convenience, as this allows for a representative 
sample to be selected from a sampling frame whereby 
all eligible individuals have an equal chance of being 
selected. In addition to this, ML- based diagnostic systems 
that are evaluated using internal validation, where the 
evaluation set is partitioned from the same cohort as 
the training set, risk learning the systematic biases in the 
data of the particular centre from which the cohort was 
drawn. Such methods only address the systems internal 
validity, and model performance may deteriorate when 
deployed on an cohort drawn from a different centre.8 
External validation, where the ML- based diagnostic 
systems are evaluated on a cohort that has played no role 
in model development, is an important step to verify and 
asses the whether the system is reliable and deployable on 
potential populations for clinical use.26–28 This is further 
highlighted in a recent systematic review evaluating the 
performance of ML algorithms for the diagnostic analysis 
of medical images; within this review, Kim et al29 found 
only 6% (31 out of 516 studies) had externally validated 
their algorithms.
Low- quality clinical research that is reported inade-
quately or that offers invalid data and distorted outcomes 
are deemed wasteful; such research is non- replicable and 
unusable.30 31 One way to increase the value and reusability 
of these novel and promising ML- based systems is through 
complete, accurate and transparent reporting.19 31. Some 
of the methodological and reporting issues facing the 
studies reviewed in this systematic review can be mitigated 
through the use of reporting guidelines such as TRIPOD 
guideline. More specifically, there has been a recent 
initiative to develop an extension of the TRIPOD state-
ment which is specific to ML studies (TRIPOD- ML).32 
Such guidelines aid researchers developing ML- based 
diagnostic systems in addressing the important aspects of 
design, execution and complete and reliable reporting 
of studies. However, no reporting guideline can salvage 
a poorly designed and executed study. To prevent flawed 
design and execution of ML methods, informatic and 
biomedical researchers looking to develop ML- based 
diagnostic systems should consult with a methodologist, 
epidemiologist or a statistician. Having input from such 
experts will aid in research that is methodological robust 
in design and execution—resulting in research that it is 
reliable, reproducible and that adds scientific value.33
Strengths and limitations of study
To our knowledge, this is the first systematic review eval-
uating the reporting quality of studies developing and/
or validating ML methods for medical diagnosis within 
the medical literature. A possible limitation within this 
review is that we have not included all medical journals 
and, therefore, our findings may not be applicable to all 
journals. Despite this, we have included studies published 
within the Medline Core Clinical Journals, these journals 
cover all areas of clinical and public health.
This review did not evaluate the statistical methodology 
and conduct of studies using ML diagnostic systems. 
This could be considered a limitation as a transparent 
reporting that does not guarantee a quality study. Never-
theless, this review shows that these studies do not comply 
with TRIPOD guideline on the reporting this considerably 
affects the trust we have in the estimates they are giving 
concerning the efficacy of their diagnostic methods. 
Another potential limitation is that the following review 
did not use risk of assessment tool, however, this is not an 
essential component for this type of review, as the main 
objective is to determine the reporting quality of studies 
and not synthesis research evidence .
COnCLuSIOn
We found that all eligible studies in this review failed to 
use reporting guidelines and the studies lacked adequate 
detail on the participants on which the diagnostic task was 
evaluated on, thus making it difficult to replicate, assess 
and interpret study findings.
Diagnostic studies using ML methods have great poten-
tial to improve clinical decision- making and take the load 
off health systems. However, studies with poor reporting 
can be more problematic than of help. Within biomed-
ical research, there is an already established framework 
and guidelines in which ML researchers can use to aid the 
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execution and reporting of ML methods for clinical diag-
nosis, with the TRIPOD guideline being the most robust 
and widely used.
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